Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 13,512 | $336.52 | $4,547,017.70 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,475,603 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.00 to $336.99, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 36,631 | $335.27 | $12,281,312.00 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,489,115 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.00 to $335.975, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4. Read SEC document |
| October 19, 2022 Filed Oct 20, 2022 18:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,547 | $335.48 | $1,189,933.37 |
DisclosureSEC source: 0001209191-22-054178 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,525,746 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.19 to $335.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 18:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,966 | $335.04 | $1,328,764.67 |
DisclosureSEC source: 0001209191-22-054056 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,529,293 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.58 to $335.33, inclusive. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 18:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,076 | $333.53 | $2,693,612.51 |
DisclosureSEC source: 0001209191-22-054056 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,533,259 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.425, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 400 | $337.56 | $135,024.00 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,541,335 Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,217 | $336.96 | $5,464,480.32 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,541,735 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.52 to $337.515, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,716 | $336.02 | $6,288,856.74 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,557,952 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.52 to $336.51, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 26,044 | $335.13 | $8,728,151.76 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,576,668 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.51 to $335.50, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 19:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,247 | $333.76 | $6,090,118.72 |
DisclosureSEC source: 0001209191-22-053950 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,602,712 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:05 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 34 | $332.76 | $11,313.84 |
DisclosureSEC source: 0000059478-22-000235 · wf-form4_166620990049110.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,002 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:10 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 30 | $332.76 | $9,982.80 |
DisclosureSEC source: 0000059478-22-000237 · wf-form4_166621020715548.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,837 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:17 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 29 | $332.76 | $9,650.04 |
DisclosureSEC source: 0000059478-22-000241 · wf-form4_166621062349451.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:14 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 30 | $332.76 | $9,982.80 |
DisclosureSEC source: 0000059478-22-000239 · wf-form4_166621045570353.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:21 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 42 | $332.76 | $13,975.92 |
DisclosureSEC source: 0000059478-22-000243 · wf-form4_166621086561869.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,085 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 20:24 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 30 | $332.76 | $9,982.80 |
DisclosureSEC source: 0000059478-22-000245 · wf-form4_166621102231184.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 17:02 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 487 | $335.08 | $163,184.45 |
DisclosureSEC source: 0001209191-22-053758 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,620,959 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.815 to $335.26, inclusive. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 17:02 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,700 | $333.75 | $901,122.30 |
DisclosureSEC source: 0001209191-22-053758 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,621,446 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.10, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| October 12, 2022 Filed Oct 13, 2022 21:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 400 | $333.50 | $133,400.40 |
DisclosureSEC source: 0001209191-22-053587 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,624,146 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $333.505, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:09 UTC |
Weems AlonzoEVP, ERM & CECO
|
GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000231 · wf-form4_166551895597171.xml · nonDerivative · entry 2 Weems Alonzo · CIK 0001869672 · EVP, ERM & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 20:09 UTC |
Weems AlonzoEVP, ERM & CECO
|
SaleCommon Stock | 656 | $326.23 | $214,006.88 |
DisclosureSEC source: 0000059478-22-000231 · wf-form4_166551895597171.xml · nonDerivative · entry 1 Weems Alonzo · CIK 0001869672 · EVP, ERM & CECO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,950 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,100 | $338.94 | $711,771.90 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,624,546 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.67 to $339.12, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,500 | $338.44 | $1,184,533.00 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,626,646 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.64 to $338.58, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,400 | $337.12 | $1,820,453.40 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,630,146 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.58 to $337.50, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,600 | $335.96 | $2,889,256.00 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,635,546 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.50 to $336.33, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 30,746 | $335.00 | $10,299,940.75 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,644,146 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.50 to $335.495, inclusive. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 98,918 | $333.89 | $33,028,126.69 |
DisclosureSEC source: 0001209191-22-053073 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,674,892 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 300 | $340.85 | $102,253.50 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,773,810 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.665 to $341.10, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,175 | $340.01 | $399,512.93 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,774,110 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.6205 to $340.52, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,718 | $339.00 | $1,599,416.15 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,775,285 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.54 to $339.535, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,189 | $338.00 | $3,105,872.81 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,780,003 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.54 to $338.53, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,525 | $337.05 | $2,536,323.83 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,789,192 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.54 to $337.53, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,197 | $336.11 | $3,427,293.28 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,796,717 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.54 to $336.535, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,116 | $334.84 | $5,061,486.79 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,806,914 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.5179 to $335.48, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 32,080 | $334.21 | $10,721,360.56 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,822,030 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.50 to $334.48, inclusive. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 17:56 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,331 | $332.86 | $7,100,130.01 |
DisclosureSEC source: 0001209191-22-051511 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,854,110 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.50 to $333.48, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), and (9) to this Form 4. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:27 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 37 | $305.09 | $11,288.33 |
DisclosureSEC source: 0000059478-22-000218 · wf-form4_166379201162271.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,968 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:31 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 33 | $305.09 | $10,067.97 |
DisclosureSEC source: 0000059478-22-000220 · wf-form4_166379227639323.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,807 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:35 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 33 | $305.09 | $10,067.97 |
DisclosureSEC source: 0000059478-22-000223 · wf-form4_166379254190858.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:40 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 32 | $305.09 | $9,762.88 |
DisclosureSEC source: 0000059478-22-000225 · wf-form4_166379279081881.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:44 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 46 | $305.09 | $14,034.14 |
DisclosureSEC source: 0000059478-22-000227 · wf-form4_166379306016099.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,043 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:47 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 33 | $305.09 | $10,067.97 |
DisclosureSEC source: 0000059478-22-000229 · wf-form4_166379325657180.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:22 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 1,000 | $301.00 | $301,000.00 |
DisclosureSEC source: 0000059478-22-000215 · wf-form4_166249570552100.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,274 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:11 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 36 | $313.94 | $11,301.84 |
DisclosureSEC source: 0000059478-22-000203 · wf-form4_166068065533414.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,771 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:14 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 32 | $313.94 | $10,046.08 |
DisclosureSEC source: 0000059478-22-000205 · wf-form4_166068088472506.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,560 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:17 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 32 | $313.94 | $10,046.08 |
DisclosureSEC source: 0000059478-22-000207 · wf-form4_166068106178799.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:20 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 31 | $313.94 | $9,732.14 |
DisclosureSEC source: 0000059478-22-000209 · wf-form4_166068122882659.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,332 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:24 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 45 | $313.94 | $14,127.30 |
DisclosureSEC source: 0000059478-22-000211 · wf-form4_166068143998173.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,954 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 20:27 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 32 | $313.94 | $10,046.08 |
DisclosureSEC source: 0000059478-22-000213 · wf-form4_166068164395088.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 963 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 15, 2022 Filed Feb 3, 2023 21:35 UTC |
Ricks David ADirector · President, Chair, and CEO
|
GiftCommon Stock | 32,467 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000027 · wf-form5_167546009467637.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,316 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.